“If the United States is going to remain the global forerunner in medical innovation, serious change is needed. The federal government needs to support, rather than impede, development. But even as it seeks to do this, new taxes on the industry under Obamacare will not only slow medical innovation in the United States but force it—and the jobs it has created—overseas. This is hardly a recipe for ‘winning the future.'”